Feature Image

Forbes Covers Medical Marijuana, Inc. Subsidiary HempMeds® Mexico’s Recent International Expansion, Interviews HempMeds® Latin America President

Posted on

SAN DIEGO, July 10, 2018 — Medical Marijuana, Inc.(OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® has garnered international news coverage on leading business news website Forbes.

A July 9, 2018, article on the Forbes website entitled “Mexico Could Make History By Treating CBD Like A Supplement, As It Should Be”talks about the many potential health and wellness benefits of cannabidiol (CBD) and quotes Raul Elizalde, President of HempMeds® Latin America, explaining how CBD should be sold in Mexico and what an impact legalizing recreational cannabis could have on the country’s decades-long, cross-border drug war.

“It was an honor to be interviewed by this publication and help inform consumers on how selling CBD as a supplement in Mexico, opposed to only as a medicine, expands the possibilities for patient access in the country,” said HempMeds® President, Latin America Raul Elizalde. “We hope that both this article and the Mexican government’s evolving views on cannabis will make it easier for citizens to experience the many benefits of CBD.”

Elizalde has been a cannabis advocate in Mexico for many years and has helped shaped the opinions on cannabis of numerous Mexican politicians and global health leaders. He facilitated HempMeds® Mexico becoming the first and only company that Mexico citizens can import legal CBD products from (with a doctor’s prescription) and even spoke at the World Health Organization’s 39th Expert Committee on Drug Dependence meeting about why CBD should not be scheduled and how it helped his daughter Grace become seizure-free.

“We’re excited that Raul has been recognized by this prestigious publication for his hard work with our company and his immense passion to help clear up the misconceptions of cannabis and CBD,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “There’s a lot of cannabis legislation progress being made in Mexico and we’re excited to see what’s next to come with the newly elected president.”

Forbes is a leading business media brand. Its website boasts an audience of over 67 million unique global monthly views and targets readers between the ages of 18-34. The brand also publishes magazine content in more than 30 countries and has over 41 million social media followers.

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer, CMW Media

P. 858-264-6600

[email protected]

www.cmwmedia.com